Helena Devos, Helena

dr. Helena Devos

Laboratoriumgeneeskunde

CHALLENGING DIAGNOSTIC ASSESSMENT OF GERMLINE RUNX1 VARIANTS IN MYELOID MALIGNANCIES: A CASE REPORT OF A PATIENT PRESENTING WITH A NOVEL GERMLINE RUNX1 VARIANT.

Brugge
21/06/2020

Early relapse detection after allogeneic stem cell transplantation by chimerism analysis based on Next Generation Sequencing of insertion/deletion polymorphisms.

Glasgow UK
29/04/2020

Donor cell-derived acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: molecular confirmation by next-generation sequencing.

Brussel
14/02/2020

Immunophenotypic and molecular phenotyping of cup-like morphology in AML.

Brussel
14/02/2020

Comparative evaluation of automated mechanical tissue dissociation for flow cytometric analysis.

01/01/2020

Droplet Digital PCR Phasing (DROP-PHASE): A Novel Method for Straightforward Detection of BCR-ABL1 Compound Mutations in Tyrosine Kinase Inhibitors Resistant Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL).

Orlando
07/12/2019

Vernieuwingen in de stamcelbank.

Brugge
06/11/2019

Plaats van mutatieanalyse bij donorselectie: 2 voorbeelden.

Drongen
17/10/2019

Celvrij DNA: nieuwe diagnostische mogelijkheden.

Brugge
09/02/2019

Clonal hematopoiesis.

Brugge
08/02/2019